Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Macy's, Inc.M · Entity 3820 | Director | June 05, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Macy's, Inc.
Report date June 05, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,348 |
Reported balance
After 2026-06-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 8,348 · Balance 8,348 F1: Each restricted stock unit represents the equivalent of one share of the Issuer's common stock. F2: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the equivalent of one share of the Issuer's common stock.
F2: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Casper Sleep Inc.
Report date January 25, 2022 · Filed January 26, 2022
Section 16 reporting ended · disclosed 2022-01-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-01-25 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-01-25 · Disposition to issuer · Disposed 129,562 · Balance 338,632 F1: Prior to the merger of Merlin Merger Sub, Inc. ("Merger Sub") with and into Casper Sleep Inc. (the "Issuer") (the "Merger") contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among the Issuer, Marlin Parent, Inc. and Merger Sub, the Reporting Person contributed 129,562 shares of the Issuer's common stock to a limited partnership affiliated with Durational Capital Management, LP in exchange for units of the limited partnership. The Issuer shares were valued at $6.90 per share, which is the amount equal to the Merger Consideration (as defined below). Row 2 · 2022-01-25 · Disposition to issuer · Disposed 338,632 · Balance 0 F2: Reflects disposition in connection with the consummation of the transactions contemplated by the Merger Agreement. On January 25, 2022, upon the closing of the Merger, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes. F3: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $19.65 · Expires 2029-07-18 | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-01-25 · Disposition to issuer · Disposed 570,000 · Balance 0 F5: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F4: The option provided for vesting as to 25% of the shares on July 15, 2020 and (i) in 36 monthly installments of 10,625 shares thereafter until July 15, 2023 and (ii) in 12 monthly installments of 3,750 shares thereafter until July 15, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Prior to the merger of Merlin Merger Sub, Inc. ("Merger Sub") with and into Casper Sleep Inc. (the "Issuer") (the "Merger") contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among the Issuer, Marlin Parent, Inc. and Merger Sub, the Reporting Person contributed 129,562 shares of the Issuer's common stock to a limited partnership affiliated with Durational Capital Management, LP in exchange for units of the limited partnership. The Issuer shares were valued at $6.90 per share, which is the amount equal to the Merger Consideration (as defined below).
F2: Reflects disposition in connection with the consummation of the transactions contemplated by the Merger Agreement. On January 25, 2022, upon the closing of the Merger, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.
F3: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.
F4: The option provided for vesting as to 25% of the shares on July 15, 2020 and (i) in 36 monthly installments of 10,625 shares thereafter until July 15, 2023 and (ii) in 12 monthly installments of 3,750 shares thereafter until July 15, 2024.
F5: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2026 Filed Jun 8, 2026 20:27 UTC | Macy's, Inc. M · Entity 3820 | GrantRestricted Stock Units · Derivative | 8,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001791887-26-000002 · wk-form4_1780950433.xml · derivative · entry 1 Arel Emilie · CIK 0001791887 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,348 Underlying: Common Stock · 8,348 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:19 UTC | Macy's, Inc. M · Entity 3820 | GrantRestricted Stock Units · Derivative | 13,456 | $0.00 | $0.00 |
DisclosureSEC source: 0000794367-25-000105 · wk-form4_1748981955.xml · derivative · entry 1 Arel Emilie · CIK 0001791887 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,456 Underlying: Common Stock · 13,456 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. Read SEC document |
| May 17, 2024 Filed May 20, 2024 20:26 UTC | Macy's, Inc. M · Entity 3820 | GrantRestricted Stock Units · Derivative | 8,209 | $0.00 | $0.00 |
DisclosureSEC source: 0000794367-24-000132 · wk-form4_1716236805.xml · derivative · entry 1 Arel Emilie · CIK 0001791887 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,209 Underlying: Common Stock · 8,209 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:15 UTC | Macy's, Inc. M · Entity 3820 | GrantRestricted Stock Units · Derivative | 10,818 | $0.00 | $0.00 |
DisclosureSEC source: 0000794367-23-000040 · primary_doc.xml · derivative · entry 1 Arel Emilie · CIK 0001791887 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,818 Underlying: Common Stock · 10,818 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 15:31 UTC | Macy's, Inc. M · Entity 3820 | GrantRestricted Stock Units · Derivative | 4,197 | $0.00 | $0.00 |
DisclosureSEC source: 0000794367-22-000059 · primary_doc.xml · derivative · entry 1 Arel Emilie · CIK 0001791887 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,197 Underlying: Common Stock · 4,197 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of one year from the grant date or the date of the Issuer's next annual meeting of shareholders. The vested shares will be automatically deferred and delivered to the reporting person six months after the reporting person's service on the Issuer's Board of Directors ends. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | Casper Sleep Inc. CSPR · Entity 131068 | Disposition to issuerStock Option · Derivative | 570,000 | $0.00 Strike: $19.65 | $0.00 |
DisclosureSEC source: 0001598674-22-000035 · wf-form4_164323439448744.xml · derivative · entry 3 Arel Emilie · CIK 0001791887 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 570,000 shares Expires 2029-07-18 F5 · price: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F4 · derivative.exercise_date: The option provided for vesting as to 25% of the shares on July 15, 2020 and (i) in 36 monthly installments of 10,625 shares thereafter until July 15, 2023 and (ii) in 12 monthly installments of 3,750 shares thereafter until July 15, 2024. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | Casper Sleep Inc. CSPR · Entity 131068 | Disposition to issuerCommon Stock | 338,632 | $6.90 | $2,336,560.80 |
DisclosureSEC source: 0001598674-22-000035 · wf-form4_164323439448744.xml · nonDerivative · entry 2 Arel Emilie · CIK 0001791887 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Merger Agreement. On January 25, 2022, upon the closing of the Merger, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes. F3 · price: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | Casper Sleep Inc. CSPR · Entity 131068 | Disposition to issuerCommon Stock | 129,562 | $6.90 | $893,977.80 |
DisclosureSEC source: 0001598674-22-000035 · wf-form4_164323439448744.xml · nonDerivative · entry 1 Arel Emilie · CIK 0001791887 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,632 F1 · price: Prior to the merger of Merlin Merger Sub, Inc. ("Merger Sub") with and into Casper Sleep Inc. (the "Issuer") (the "Merger") contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among the Issuer, Marlin Parent, Inc. and Merger Sub, the Reporting Person contributed 129,562 shares of the Issuer's common stock to a limited partnership affiliated with Durational Capital Management, LP in exchange for units of the limited partnership. The Issuer shares were valued at $6.90 per share, which is the amount equal to the Merger Consideration (as defined below). Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 19:45 UTC | Casper Sleep Inc. CSPR · Entity 131068 | SaleCommon Stock | 19,223 | $7.21 | $138,597.83 |
DisclosureSEC source: 0001598674-21-000032 · wf-form4_161533712137868.xml · nonDerivative · entry 2 Arel Emilie · CIK 0001791887 · CCO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,194 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell-to-cover election to satisfy tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 19:45 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 196,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001598674-21-000032 · wf-form4_161533712137868.xml · nonDerivative · entry 1 Arel Emilie · CIK 0001791887 · CCO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,417 F1 · shares: The Reporting Person received an award of 196,507 restricted stock units on March 5, 2021. The restricted stock units vest as to (i) 25% on March 5, 2022; (ii) 25% on March 5, 2023; (iii) 25% on March 5, 2024 and (iv) 25% on March 5, 2025. Each restricted stock unit represents a right to receive one share of Issuer common stock upon vesting. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 16:03 UTC | Casper Sleep Inc. CSPR · Entity 131068 | SaleCommon Stock | 3,882 | $9.47 | $36,762.54 |
DisclosureSEC source: 0001598674-21-000024 · wf-form4_161463257885879.xml · nonDerivative · entry 2 Arel Emilie · CIK 0001791887 · CCO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,910 F2 · kind: The shares were sold to cover the Reporting Person's tax obligation upon the settlement of the performance-based restricted stock units. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 16:03 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 10,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001598674-21-000024 · wf-form4_161463257885879.xml · nonDerivative · entry 1 Arel Emilie · CIK 0001791887 · CCO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,792 F1 · kind: The shares of common stock were acquired pursuant to the vesting of performance-based restricted stock units following the certification by the Board of Directors of Casper Sleep Inc. of the achievement of certain performance criteria. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 16:32 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 183,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001598674-20-000056 · wf-form4_160521672749734.xml · nonDerivative · entry 1 Arel Emilie · CIK 0001791887 · CCO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,249 F1 · security: The Reporting Person received an award of 183,287 restricted stock units on November 10, 2020. The restricted stock units vest as to (i) 50% on November 10, 2021 and (ii) 50% on November 10, 2022. Each restricted stock unit represents a right to receive one share of Issuer common stock upon vesting. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 17:38 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 100,962 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-030860 · a4.xml · nonDerivative · entry 1 Arel Emilie · CIK 0001791887 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,962 F1 · shares: The Reporting Person received an award of 100,962 restricted stock units on March 5, 2020. The restricted stock units vest as to (i) 50% on March 5, 2021; (ii) 25% on March 5, 2022 and (iii) 25% on March 5, 2023. Each restricted stock unit represents a right to receive one share of Issuer common stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.